Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
WO	A2	WO2007022305	Aug 16, 2006	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITHOUT INTERNATIONAL SEARCH REPORT or INTERNATIONAL APPLICATION PUBLISHED WITH DECLARATION UNDER ARTICLE 17 (2) (A)		2-AMINOIMIDAZOPYRIDINES FOR TREATING NEURODEGENERATIVE DISEASES		Feb 22, 2007

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
PHARMACOPEIA LLC	C/O LIGAND PHARMACEUTICALS INC 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Brescia, Marc-Raleigh	Dayton, NJ	7	23
# of filed Patents : 7 Total Citations : 23
Cole, Andrew G	Robbinsville, NJ	32	167
# of filed Patents : 32 Total Citations : 167
Dong, Guizhen	Dayton, NJ	16	155
# of filed Patents : 16 Total Citations : 155
Henderson, Ian	Hopewell, NJ	48	395
# of filed Patents : 48 Total Citations : 395
McGuinness, Brian F	Plainsboro, NJ	28	465
# of filed Patents : 28 Total Citations : 465
Shao, Yuefei	Princeton, NJ	15	433
# of filed Patents : 15 Total Citations : 433

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 2 Citation Count
• A61K Class

• 11.28 % this patent is cited more than
• 17 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2008/0146,536

2-Aminoimidazopyridines for treating neurodegenerative diseases

---

Abstract

---

The invention relates to 2-aminoimidazopyridine derivatives useful in treating disorders that are mediated by A.sub.2a receptor function, including neurodegenerative diseases including Parkinson's disease and inflammation. The compounds have general formula I:

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.